Advanced Search
Users Online: 375
About
About Journal
Editorial Board
Articles
Ahead of Print
Current Issue
Archives
Authors
Submit Article
Instructions
Search
Simple Search
Advanced Search
Image Search
Medline Search
Subscribe
Contact Us
Reader Login
Sign Up
Subscriber Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Citation statistics : Table of Contents
2018| October-December | Volume 12 | Issue 4
Online since
December 18, 2018
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Cited
Viewed
PDF
INVITED COMMENTARY
Viral nephropathies in renal transplantation with a special emphasis on adenovirus infection
Praveen Kumar Etta
October-December 2018, 12(4):233-235
DOI
:10.4103/ijot.ijot_38_18
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
4
596
133
CASE REPORTS
Management of chronic parvovirus infection in postkidney transplant with prophylactic intravenous immunoglobulin therapy
Manmeet Singh Jhawar, Pratish George, Chepsy C Philips, Kanwardeep Singh Kwatra, Jasmin Das, M Joseph John
October-December 2018, 12(4):247-250
DOI
:10.4103/ijot.ijot_39_17
Parvovirus (PV) infection is a rare cause of persistent anemia in kidney transplant recipients. The diagnosis of PV infection depends on a high index of suspicion, persistent anemia, red cell aplasia in the bone marrow, and positive polymerase chain reaction for PV B19. Treatment with intravenous immunoglobulin (IVIg) has shown to improve anemia but persistence of PV is common after treatment. This case report highlights a postkidney transplant recipient who had PV infection, treated with IVIg but had multiple relapses. He was managed with monthly IVIg prophylactic therapy for 6 months following which he had complete clearance of PV. PV B19 results in multiple relapses in postkidney transplant patients. Monthly prophylaxis therapy with higher dose delivery of IVIg can result in the clearance of PV and relapse-free response. Further studies may be required to determine the duration of prophylaxis therapy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
1
693
120
A case of postkidney transplant patient with gastric tuberculosis mimicking gastric malignancy
Manoj Kumar Singhal, Anuja Porwal, Rohit Khandelwal, Mukul Rastogi
October-December 2018, 12(4):251-253
DOI
:10.4103/ijot.ijot_49_18
A 60-year-old male patient, who is a known case of end-stage kidney disease postliving donor renal transplantation on triple maintenance immunosuppression, presented with persistent dyspeptic symptoms 8 months posttransplant, not relieved with prolonged proton-pump inhibitor therapy. On endoscopy, found to have large ulcerated nodular lesion in the body of stomach suggestive of malignancy. On biopsy, it was diagnosed with primary gastric tuberculosis (TB). Complete clinical and endoscopic resolution was achieved following anti-TB treatment.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
1
613
124
ABSTRACTS
Abstracts
October-December 2018, 12(4):254-304
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
3,236
176
ORIGINAL ARTICLE
Noisy orchestra - Renal transplant and urinary tract infections
Ajaz Nabi Koul, Aadil Rafeeq Rather, Imtiaz Ahmad Wani, M Saleem Wani, Bashir Ahmad Fomda
October-December 2018, 12(4):243-246
DOI
:10.4103/ijot.ijot_28_18
Introduction:
Kidneys are the most frequently transplanted organs; renal transplantation is the preferred method for treating patients with chronic kidney disease; and posttransplantation urinary tract infection (UTI) is still a source of morbidity and graft failure.
Materials and Methods:
This prospective study was conducted during the period of August 2016 to February 2018. A total of 35 renal transplant recipients were included in the study.
Results:
The most common symptom associated with the infection was dysuria (71%). Only 66% of the cases were febrile. Almost 17% of the cases presented with shock. Urine culture was positive in 23 (65%) cases, with bacteria in 22 (96%) and fungus in 1 (4%). Predominant bacteria grown from cultures were
Klebsiella pneumoniae
32%,
Pseudomonas aeruginosa
18%,
Escherichia coli
14%,
Enterococcus faecalis
13%,
Acinetobacter
10%,
Staphylococcus aureus
9%, and
Enterobacter
4%. Antibiotic resistance profiles showed a high resistance patterns to ceftriaxone 60%, levofloxacin 53%, nitrofurantoin 53%, ciprofloxacin 40%, cotrimoxazole 40%, piperacillin–tazobactam 26%, amikacin 26%, gentamicin 26%, meropenem 26%, and imipenem 13%. Patients were followed up over a period of 4 weeks. At the 2
nd
week of follow-up, 2 (5%) cases were still culture positive, and the symptoms of UTI persisted in 6 (17%) cases. Of 35 cases, 25 were followed up till the 4
th
week. Culture positive was noted in 6 (24%) cases, and the symptoms persisted in 10 (40%) cases. In recurrent infections, relapses were noted in 3 (50%) cases and reinfections in 3 (50%).
Conclusion:
In these high-risk patients, antibiotic selection, duration, and stewardship need to be readdressed. Microbial profile and sensitivity patterns in such patients are different from the usual UTIs.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
1,075
188
REVIEW ARTICLE
Modulation of maintenance immunosuppression during infection in renal transplant recipients
M Edwin Fernando, R Vivek Praveen, A Ishwarya
October-December 2018, 12(4):236-242
DOI
:10.4103/ijot.ijot_25_18
Infection occurs commonly after renal transplantation, and it is associated with significant morbidity and mortality. Infections are commonly associated with changes in the white blood cell count; however, it may be masked in the background of immunosuppression. Immunosuppression modulation during infection is crucial, keeping in mind, the risk of rejection on the one hand and risk of severe infection and mortality on the other hand. Idea about timeline of infection after renal transplantation in a particular geographical area is helpful in management of infection. The approach to modulate immunosuppressive agents will vary depending on the severity of infection. Many infections require specific anti-infective agents which may have significant drug interaction with immunosuppressive agents. It may also necessitate stoppage of immunosuppression either temporarily or permanently in severe infections to salvage the life of the patient.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
2,700
487
© Indian Journal of Transplantation | Published by Wolters Kluwer -
Medknow
Sitemap
|
What's New
|
Feedback
|
Disclaimer
FAQ
Online since 9
th
June,2017